Hjem › Multipelt myelom › Virginia › Arlington
Kliniske studier for Multipelt myelom i Arlington, VA
9 studier for Multipelt myelom søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekruttererFase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 278716, Fairfax · 11 mi unna
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruttererFase 1/2
- Research Site, Fairfax · 11 mi unna
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Fairfax · 11 mi unna
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi unna
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Fairfax · 11 mi unna
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruttererFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft46 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Tripelnegativ brystkreft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.